Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61.8M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
11.8K
-
Shares change
-
-22.7K
-
Total reported value, excl. options
-
$104K
-
Value change
-
-$203K
-
Number of sells
-
-1
-
Price
-
$8.86
Significant Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q4 2023
2 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock as of Q4 2023.
Aura Biosciences, Inc. - Common Stock (AURA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8K shares
of 61.8M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (6.92M shares), EVENTIDE ASSET MANAGEMENT, LLC (5.8M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.23M shares), CITADEL ADVISORS LLC (3.63M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), BlackRock Inc. (2.1M shares), VANGUARD GROUP INC (1.73M shares), Nantahala Capital Management, LLC (1.32M shares), GOLDMAN SACHS GROUP INC (1.04M shares), and Regency Capital Management Inc.\DE (705K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.